rFSH Versus Transvaginal Hydrolaparoscopic Ovarian Drilling in Patients with Polycystic Ovary Syndrome Resistant to Ovulation Induction

Abstract

OBJECTIVE: To compare outcomes of recombinant follicle-stimulating hormone (rFSH) treatment with transvaginal hydrolaparoscopic ovarian drilling (THLOD) procedure in patients with polycystic ovary syndrome (PCOS) resistant to ovulation induction with clomiphene citrate (CC).